The role of radical prostatectomy as an initial approach for the treatment of high-risk prostate cancer

被引:2
|
作者
Jaunarena, J. H. [1 ]
Villamil, W. [1 ]
Martinez, P. F. [1 ]
Gueglio, G. [1 ]
Giudice, C. R. [1 ]
机构
[1] Hosp Italiano Buenos Aires, Serv Urol, Buenos Aires, DF, Argentina
来源
ACTAS UROLOGICAS ESPANOLAS | 2016年 / 40卷 / 06期
关键词
Prostate cancer; High-risk; Radical prostatectomy; Biochemical recurrence; Radiation therapy; Cancer-specific mortality; EXTERNAL-BEAM RADIOTHERAPY; METASTATIC PROGRESSION; RANDOMIZED-TRIAL; MORTALITY; THERAPY; DEFINITION; MANAGEMENT; OUTCOMES; IMPACT; MEN;
D O I
10.1016/j.acuro.2015.12.004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Context: The treatment of high-risk prostate cancer requires a multimodal approach to improve control of the disease. There is still no consensus as to the initial strategy of choice. The aim of this study is to review the results of radical prostatectomy as first step in management of patients with high-risk disease. Acquisition of evidence: A search was conducted on PubMed of English and Spanish texts. We included those studies that reported the results of radical prostatectomy in patients with high risk prostate cancer, as well as those that compared radical prostatectomy with other treatment alternatives. The last search was conducted in November 2015. Synthesis of the evidence: The advantages of radical prostatectomy include a better pathological analysis, more accurate staging, better local control of the disease and better follow-up and adjuvant therapy strategies. When compared with external radiation therapy plus hormonal blockade, the patients who underwent prostatectomy had greater chances of healing and longer cancer-specific survival. The patients who most benefit from this approach are younger, have fewer comorbidities and no evidence of organ metastases. Conclusions: The available scientific evidence to date is not without bias and confounders; however, they appear to favour radical prostatectomy as the initial approach of choice for high-risk prostate cancer. (C) 2015 AEU. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:353 / 360
页数:8
相关论文
共 50 条
  • [1] Role of radical prostatectomy in the treatment of high-risk prostate cancer
    Yossepowitch O.
    Eastham J.A.
    Current Urology Reports, 2008, 9 (3) : 203 - 210
  • [2] The Role of Radical Prostatectomy in the Treatment of Patients with High-Risk Prostate Cancer
    Kuzgunbay, Baris
    Yaycioglu, Ozgur
    JOURNAL OF UROLOGICAL SURGERY, 2015, 2 (03): : 120 - 123
  • [3] Role of Radical Prostatectomy for High-Risk Prostate Cancer
    You, Dalsan
    Jeong, In Gab
    Kim, Choung-Soo
    KOREAN JOURNAL OF UROLOGY, 2010, 51 (09) : 589 - 595
  • [4] The role of radical prostatectomy in high-risk prostate cancer
    Chung, Byung Ha
    PROSTATE INTERNATIONAL, 2013, 1 (03) : 95 - 101
  • [5] High-risk localized prostate cancer: role of radical prostatectomy
    Grubb, Robert L.
    Kibel, Adam S.
    CURRENT OPINION IN UROLOGY, 2010, 20 (03) : 204 - 210
  • [6] Role of radical prostatectomy for high-risk localized prostate cancer
    Matsubara, A.
    Teishima, J.
    Yasumoto, H.
    Usui, T.
    Nakamoto, T.
    Maruyama, S.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 180 - 180
  • [7] Avoiding Androgen Deprivation Therapy in Men With High-risk Prostate Cancer: The Role of Radical Prostatectomy as Initial Treatment
    Miocinovic, Ranko
    Berglund, Ryan K.
    Stephenson, Andrew J.
    Jones, J. Stephen
    Fergany, Amr
    Kaouk, Jihad
    Klein, Eric A.
    UROLOGY, 2011, 77 (04) : 946 - 950
  • [8] Radical Prostatectomy as Primary Treatment of High-risk Prostate Cancer
    Ingels, Alexandre
    de la Taille, Alexandre
    Ploussard, Guillaume
    CURRENT UROLOGY REPORTS, 2012, 13 (02) : 179 - 186
  • [9] Radical Prostatectomy as Primary Treatment of High-risk Prostate Cancer
    Alexandre Ingels
    Alexandre de la Taille
    Guillaume Ploussard
    Current Urology Reports, 2012, 13 : 179 - 186
  • [10] Radical prostatectomy for high-risk prostate cancer
    Ofer Yossepowitch
    James A. Eastham
    World Journal of Urology, 2008, 26 : 219 - 224